Index of /wp-content/uploads/2023/06

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory   -  
[IMG]MQCD-ISO-IEC-17025-2..>2023-06-06 10:40 5.7K 
[IMG]PDF_file_icon.svg-15..>2023-06-07 12:23 12K 
[IMG]MQCD-ISO-IEC-17025-2..>2023-06-06 10:40 14K 
[ ]PATIENT-INFORMATION-..>2023-06-05 15:10 24K 
[IMG]MQCD-ISO-IEC-17025-2..>2023-06-06 11:50 30K 
[ ]SUMMARY-OF-PRODUCT-C..>2023-06-05 16:09 36K 
[IMG]PDF_file_icon.svg-24..>2023-06-07 12:23 37K 
[IMG]PDF_file_icon.svg.png 2023-06-07 12:23 38K 
[IMG]image-150x150.png 2023-06-06 17:15 41K 
[IMG]MQCD-ISO-IEC-17025-2..>2023-06-06 10:40 66K 
[IMG]image-300x155.png 2023-06-06 17:15 81K 
[ ]Letter-to-Market-Aut..>2023-06-22 11:42 100K 
[ ]COVISHIELD-vaccine-r..>2023-06-06 11:22 181K 
[ ]Report-of-Pfizer-vac..>2023-06-06 11:35 205K 
[ ]MQCD-ISO-IEC-17025-2..>2023-06-06 10:37 219K 
[ ]Janssen-AEFI-Active-..>2023-06-06 11:29 233K 
[ ]Janssen-AEFI-Active-..>2023-06-06 11:34 233K 
[ ]EFDA-Vaccine-Safety-..>2023-06-02 21:00 238K 
[ ]AEFI-SURVEILLANCE-CO..>2023-06-05 10:43 246K 
[ ]Prevalence-Intensity..>2023-06-08 17:03 293K 
[IMG]PDF_file_icon.svg-76..>2023-06-07 12:23 297K 
[ ]PV-Trainer-Guide-May..>2023-06-05 10:42 298K 
[ ]NTD-PV-guideline.pdf 2023-06-02 21:02 313K 
[ ]NCD-PV-guideline.pdf 2023-06-02 21:01 314K 
[ ]Antimalarial-PV-guid..>2023-06-02 21:03 314K 
[ ]HIV-PV-guideline.pdf 2023-06-02 21:04 321K 
[ ]TB-PV-guideline.pdf 2023-06-02 21:05 335K 
[ ]List-of-GCP-Inspecto..>2023-06-05 13:29 356K 
[ ]list-of-GCP-Inspecto..>2023-06-04 12:12 356K 
[ ]Clinical-Trial-appli..>2023-06-07 13:10 369K 
[ ]Adverse-Drug-Events-..>2023-06-06 11:09 387K 
[ ]List-of-recalled-med..>2023-06-07 12:01 405K 
[ ]Clinical-Trial-Autho..>2023-06-07 11:38 435K 
[ ]Guidelines-for-Regis..>2023-06-07 17:42 453K 
[IMG]image-768x398.png 2023-06-06 17:15 469K 
[ ]LIST-OF-SUSPENDED-ME..>2023-06-10 11:49 511K 
[ ]Clinical-Trial-Autho..>2023-06-08 11:37 540K 
[ ]CTA-Guideline-3rd-ed..>2023-06-12 10:54 542K 
[ ]LIST-OF-CANCELED-MED..>2023-06-10 11:49 544K 
[ ]Baseline-assessment-..>2023-06-06 11:12 575K 
[ ]Guideline-on-Medical..>2023-06-08 10:30 580K 
[ ]LIST-OF-MEDICINES-SI..>2023-06-08 11:24 629K 
[ ]List-of-medicines-se..>2023-06-09 12:00 629K 
[ ]ADE-aDSM-Preliminary..>2023-06-06 11:05 659K 
[ ]List-of-Medicines-fo..>2023-06-09 12:10 706K 
[ ]GMP-trend-Analysis-r..>2023-06-16 13:50 776K 
[ ]Guidelines-for-Regis..>2023-06-07 17:40 786K 
[ ]Comparative-Assessme..>2023-06-06 11:17 824K 
[ ]National-Pharmacovig..>2023-06-04 12:02 825K 
[ ]Efficacy-and-safety-..>2023-06-06 11:28 833K 
[IMG]image.png 2023-06-06 17:14 833K 
[ ]Medicines-Waste-Mana..>2023-06-07 11:07 834K 
[ ]Inspection-of-FY-22-..>2023-06-16 13:30 856K 
[ ]Inspection-of-FY-22-..>2023-06-16 13:31 856K 
[ ]List-of-Medicines-fo..>2023-06-09 12:13 917K 
[ ]List-of-Authorized-p..>2023-06-05 13:22 936K 
[ ]List-of-Authorized-p..>2023-06-05 13:23 936K 
[ ]CEM-ART-drugs-2016-2..>2023-06-08 17:12 1.0M 
[ ]List-of-unregistered..>2023-06-07 16:54 1.0M 
[ ]List-of-pharmaceutic..>2023-06-04 12:10 1.1M 
[ ]List-of-GMP-inspecto..>2023-06-04 12:11 1.2M 
[ ]AEFI-Training-Manual..>2023-06-05 10:41 1.2M 
[ ]PV-Training-for-Heal..>2023-06-05 10:40 1.3M 
[ ]A-blueprint-for-stre..>2023-06-08 17:07 1.3M 
[ ]EFDA-GMP-Guideline-f..>2023-06-02 10:53 1.3M 
[ ]EFDA-organizational-..>2023-06-11 11:05 1.3M 
[ ]Medicine-and-Medical..>2023-06-05 16:29 1.4M 
[ ]Guidelines-for-Consu..>2023-06-04 12:03 1.5M 
[ ]iLicense-User-Manual..>2023-06-09 16:33 1.6M 
[ ]List-of-authorized-p..>2023-06-04 12:16 1.6M 
[ ]List-of-authorized-p..>2023-06-02 21:10 1.6M 
[ ]EFDA-organizational-..>2023-06-27 17:38 1.6M 
[ ]Health-Policy.pdf 2023-06-07 18:00 1.8M 
[ ]Food-and-Health-Prod..>2023-06-05 13:45 1.9M 
[ ]FHRSTP-II-Performanc..>2023-06-05 16:15 1.9M 
[ ]Definition-of-Powers..>2023-06-05 16:35 1.9M 
[ ]Proclamation-No.-126..>2023-06-05 16:31 1.9M 
Apache/2.4.35 (Win64) OpenSSL/1.1.0i PHP/7.2.10 Server at www.efda.gov.et Port 80